Randomized Phase II Trial Comparing Carboplatin Plus Weekly Paclitaxel and Docetaxel Alone in Elderly Patients With Advanced Non-Small Cell Lung Cancer: North Japan Lung Cancer Group Trial 0801

BACKGROUND. Standard first-line chemotherapy for elderly non-small cell lung cancer (NSCLC) patients has been monotherapy with vinorelbine or gemcitabine. Docetaxel has also been considered as an alternative option for the elderly population in Japan. We have previously demonstrated the high efficac...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Maemondo, Makoto, Inoue, Akira, Sugawara, Shunichi, Harada, Toshiyuki, Minegishi, Yuji, Usui, Kazuhiro, Miwa, Koji, Morikawa, Naoto, Kambe, Mariko, Ube, Kenji, Watanabe, Kana, Ishimoto, Osamu, Sakakibara, Tomohiro, Gemma, Akihiko, Nukiwa, Toshihiro
פורמט: Artigo
שפה:Inglês
יצא לאור: AlphaMed Press 2014
נושאים:
Clinical Trial Results
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3983823/
https://ncbi.nlm.nih.gov/pubmed/24682465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2013-0411
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים